EPGNF
Price:
$1.12
Market Cap:
$612.61K
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was foun...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2010-12-31
Stock Exchange
OTC
Ticker
EPGNF
According to Epigenomics AG’s latest financial reports and current stock price. The company's current PE Ratio is -0.30. This represents a change of -74.43% compared to the average of -1.17 of the last 4 quarters.
The mean historical PE Ratio of Epigenomics AG over the last ten years is -128.87. The current -0.30 PE Ratio has changed -76.72% with respect to the historical average. Over the past ten years (40 quarters), EPGNF's PE Ratio was at its highest in in the September 2021 quarter at 1.29. The PE Ratio was at its lowest in in the December 2016 quarter at -1719.41.
Average
-128.87
Median
-8.78
Minimum
-707.20
Maximum
-2.88
Discovering the peaks and valleys of Epigenomics AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 282.77%
Maximum Annual PE Ratio = -2.88
Minimum Annual Increase = -99.33%
Minimum Annual PE Ratio = -707.20
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -2.88 | -2.83% |
| 2021 | -2.96 | -64.28% |
| 2020 | -8.28 | -45.66% |
| 2019 | -15.24 | 282.77% |
| 2018 | -3.98 | -63.13% |
| 2017 | -10.80 | 16.38% |
| 2016 | -9.28 | 95.41% |
| 2015 | -4.75 | -99.33% |
| 2014 | -707.20 | 35.14% |
| 2013 | -523.30 | 103.94% |
The current PE Ratio of Epigenomics AG (EPGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.71
5-year avg
-6.67
10-year avg
-128.87
Epigenomics AG’s PE Ratio is less than Unity Biotechnology, Inc. (0), less than Telesis Bio, Inc. (-0.00), less than Body and Mind Inc. (-0.12), greater than RushNet, Inc. (-0.71), greater than NovelStem International Corp. (-0.55), greater than PPJ Healthcare Enterprises, Inc. (-292.25), less than Health Logic Interactive Inc. (0.76), less than China Medicine Corporation (0.36), greater than Procyon Corporation (-2.88), less than Next Generation Management Corp. (0.40),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0 | $965.60K | |
| -0.00 | $1.65M | |
| -0.12 | $14.63K | |
| -0.71 | $428.82K | |
| -0.55 | $937.63K | |
| -292.25 | $890.48K | |
| 0.76 | $302.70K | |
| 0.36 | $948.48K | |
| -2.88 | $982.57K | |
| 0.40 | $935.37K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Epigenomics AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Epigenomics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Epigenomics AG's PE Ratio?
How is the PE Ratio calculated for Epigenomics AG (EPGNF)?
What is the highest PE Ratio for Epigenomics AG (EPGNF)?
What is the 3-year average PE Ratio for Epigenomics AG (EPGNF)?
What is the 5-year average PE Ratio for Epigenomics AG (EPGNF)?
How does the current PE Ratio for Epigenomics AG (EPGNF) compare to its historical average?